Transplantation Direct (May 2024)

Very Low Frequency of Pathological Findings in One-year Protocol Biopsies of Uneventful Standard Risk Kidney Transplant Recipients: Results From the Nordic Protocol Biopsy Study

  • Ilkka Helanterä, MD, PhD,
  • Christina Dörje, MD, PhD,
  • Fernanda Ortiz, MD, PhD,
  • Anna Varberg Reisæter, MD, PhD,
  • Clara Hammarström, MD,
  • Jouni Lauronen, MD, PhD,
  • Anne Räisänen-Sokolowski, MD, PhD,
  • Anders Johan Haugen, MD, PhD,
  • Marko Lempinen, MD, PhD,
  • Anders Åsberg, PhD,
  • Geir Mjøen, MD, PhD

DOI
https://doi.org/10.1097/TXD.0000000000001621
Journal volume & issue
Vol. 10, no. 5
p. e1621

Abstract

Read online

Background. The clinical significance of kidney transplant protocol biopsies has been debated. We studied the frequency of borderline changes and T cell–mediated rejection (TCMR) in 1-y protocol biopsies in standard risk kidney transplant recipients. Methods. Consecutive non-HLA-sensitized recipients of kidney transplants between 2006 and 2017, who underwent a protocol biopsy at 1 y in 2 national transplant centers were studied retrospectively (N = 1546). Donor-specific HLA antibodies (DSAs), graft function (plasma creatinine), and proteinuria were measured at the time of 1-y protocol biopsy. The occurrence of subclinical acute TCMR (i2t2v0 or higher) or borderline changes suspicious of TCMR (i1t1v0 or higher) in the protocol biopsy was studied, together with frequency of findings causing changes in the composite score iBox. Results. Subclinical acute TCMR was detected in 30 of 1546 (1.9%) of the protocol biopsies, and borderline or TCMR in 179 of 1546 (12%). Among patients with no history of acute rejection, and no proteinuria or DSA, TCMR was detected in only 1 of 974 (0.1%) and borderline or TCMR in only 48 of 974 (4.9%) patients at 1 y. In the absence of proteinuria (<30 mg/g, or equivalent as measured with a negative dipstick proteinuria) or DSA, or history of acute rejection, only 50 of 974 (5.1%) biopsies showed any lesions significant for the iBox score. Conclusions. The likelihood of pathological findings in 1-y protocol biopsies in non-HLA-sensitized patients without previous immunological events is low. Clinical usefulness of protocol biopsies seems limited in these patients.